Bliss GVS Pharma Ltd (BLIS)

Currency in INR
573.80
+27.30(+5.00%)
Closed·
Trading near 52-week High
BLIS is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
554.10573.80
52 wk Range
118.00573.80
Key Statistics
Bid/Ask
573.80 / 573.80
Prev. Close
546.5
Open
565
Day's Range
554.1-573.8
52 wk Range
118-573.8
Volume
1.03M
Average Volume (3m)
1.48M
1-Year Change
229.827%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
BLIS Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Bliss GVS Pharma Ltd News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
Aug 12, 2026
EPS / Forecast
4.65 / --
Revenue / Forecast
2.86B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 12.62%
Dividend Yield
0.27%
Industry Median 0.66%
Annualized payout
1.50
Paid unevenly
5-Years Growth
+24.57%
Growth Streak

BLIS Income Statement

Compare BLIS to Peers and Sector

Metrics to compare
BLIS
Peers
Sector
Relationship
P/E Ratio
44.7x31.6x−0.3x
PEG Ratio
1.770.420.00
Price/Book
5.1x3.6x2.6x
Price / LTM Sales
6.1x5.9x3.1x
Upside (Analyst Target)
-3.0%50.4%
Fair Value Upside
Unlock1.2%6.4%Unlock

Bliss GVS Pharma Limited engages in the development, manufacturing and marketing of pharmaceutical formulations in India and internationally. The company offers anti-diabetic, anti-infective, anti-inflammatory, antifungal, antihemorrhoidal, antimalarial, antiseptic, cardiovascular, dermatological, gastrointestinal, gynaecology, neoro/cns, ophthalmic, otc drugs, respiratory, urology, and supplementary drug products, as well as engages in pain management services. It exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Employees
1033
Market
India

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.08M1.02%560.83M
Other Institutional Investors
24.10M22.78%12.54B
Public Companies & Retail Investors
80.61M76.20%41.96B
Total
105.79M100.00%55.06B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Gulbarga Trading and Investment Private Limited5.51%5,832,0003,035,556
Life Insurance Corporation of India4.33%4,578,0912,382,896

People Also Watch

419.80
BHEL
-1.22%
284.56
CUCO
+0.19%
3,352.00
BSEL
+1.33%
226.53
HFCL
-1.52%

FAQ

What Is the Bliss GVS Pharma Ltd (BLIS) Stock Price Today?

The Bliss GVS Pharma Ltd stock price today is 573.80 INR.

What Stock Exchange Does Bliss GVS Pharma Ltd Trade On?

Bliss GVS Pharma Ltd is listed and trades on the India National Stock Exchange.

What Is the Stock Symbol for Bliss GVS Pharma Ltd?

The stock symbol for Bliss GVS Pharma Ltd is "BLIS."

Does Bliss GVS Pharma Ltd Pay Dividends? What’s The Current Dividend Yield?

The Bliss GVS Pharma Ltd dividend yield is 0.35%.

What Is the Bliss GVS Pharma Ltd Market Cap?

As of today, Bliss GVS Pharma Ltd market cap is 60.85B INR.

What Is Bliss GVS Pharma Ltd's Earnings Per Share (TTM)?

The Bliss GVS Pharma Ltd EPS (TTM) is 12.62.

From a Technical Analysis Perspective, Is BLIS a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Bliss GVS Pharma Ltd Stock Split?

Bliss GVS Pharma Ltd has split 1 times.

How Many Employees Does Bliss GVS Pharma Ltd Have?

Bliss GVS Pharma Ltd has 1033 employees.

What is the current trading status of Bliss GVS Pharma Ltd (BLIS)?

As of Aug 19, 2026, Bliss GVS Pharma Ltd (BLIS) is trading at a price of 573.80 INR, with a previous close of 546.50 INR. The stock has fluctuated within a day range of 554.10 INR to 573.80 INR, while its 52-week range spans from 118.00 INR to 573.80 INR.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.